| Literature DB >> 31474851 |
Ashwin R Sakhare1,2, Vincent Yang1,2, Joy Stradford2, Ivan Tsang2, Roshan Ravichandran2, Judy Pa1,2.
Abstract
BACKGROUND: Cognitive decline is a significant public health concern in older adults. Identifying new ways to maintain cognitive and brain health throughout the lifespan is of utmost importance. Simultaneous exercise and cognitive engagement has been shown to enhance brain function in animal and human studies. Virtual reality (VR) may be a promising approach for conducting simultaneous exercise and cognitive studies. In this study, we evaluated the feasibility of cycling in a cognitively enriched and immersive spatial navigation VR environment in younger and older adults.Entities:
Keywords: cycling; exercise; older adults; virtual reality; younger adults
Year: 2019 PMID: 31474851 PMCID: PMC6706817 DOI: 10.3389/fnagi.2019.00218
Source DB: PubMed Journal: Front Aging Neurosci ISSN: 1663-4365 Impact factor: 5.702
FIGURE 1Top left, beam of light serves as a visual cue to orient the participant in the direction of the destination. Top right, landmark located at intersection to serve as a visual cue for encoding the correct route in memory. Bottom left, tunneling effect at intersection to mitigate adverse effects due to sensory conflict when turning. Bottom right, directional arrows on ground and at intersection guide participant to destination on the first two trials.
Mean, standard deviation, and significance values are reported in this table for participant demographics and performance in the VR environment.
| Age (years) | 45 ± 19.7 | 26 ± 3.7 | 64 ± 5.6 | |
| Gender (M/F) | 21/19 | 11/9 | 10/10 | NS |
| VR experience (Y/N) | 27/13 | 15/5 | 12/8 | NS |
| IPD | 62 ± 3.3 | 62 ± 4.3 | 63 ± 1.7 | NS |
| SBP | 141 ± 13.9 | – | 141 ± 13.9 | |
| DBP | 86 ± 11.0 | – | 86 ± 11.0 | |
| Correct decisions (%) | 99 ± 2.7 | 99 ± 1.4 | 98 ± 3.4 | NS |
| Mean speed (mph) | 15 ± 3.9 | 16 ± 3.5 | 14 ± 4.3 | NS |
| Trial times (min) | ||||
| Total | 10 ± 3.0 | 9 ± 1.7 | 11 ± 3.9 | NS |
| Mean | 2.7 ± 1.0 | 2.4 ± 0.5 | 3.0 ± 3.0 | 0.07 |
| Baseline | 7.7 ± 2.2 | 8.6 ± 2.8 | 6.9 ± 0.9 | 0.77 |
| Trial 1 | 11.2 ± 2.6 | 11.9 ± 2.1 | 10.5 ± 2.8 | 0.02 |
| Trial 2 | 11.9 ± 2.5 | 12.8 ± 2.1 | 11.2 ± 2.8 | 0.09 |
| Trial 3 | 12.5 ± 2.8 | 13.5 ± 2.2 | 11.5 ± 3.1 | 0.01 |
| Trial 4 | 12.8 ± 3.0 | 14.1 ± 2.3 | 11.3 ± 3.1 | 0.03 |
| 14 ± 2.3 | 12 ± 3.2 | 13 ± 2.9 | 0.03 | |
Mean, standard deviation, and significance values are shown for participant responses to presence, mood, and adverse effects questionnaires.
| MSSQ (percentile) | 54 ± 29.9 | 58 ± 29.0 | 49 ± 30.9 | NS |
| Involvement | 4.9 ± 0.8 | 4.8 ± 0.8 | 4.9 ± 0.8 | NS |
| Sensory fidelity | 4.4 ± 1.1 | 4.6 ± 0.9 | 4.1 ± 1.2 | NS |
| Adaptation/immersion | 5.5 ± 0.7 | 5.5 ± 0.6 | 5.5 ± 0.7 | NS |
| Interface quality | 3.2 ± 1.4 | 3.2 ± 1.3 | 3.2 ± 1.5 | NS |
| Spatial presence | 3.4 ± 0.4 | 3.3 ± 0.4 | 3.4 ± 0.4 | NS |
| Engagement | 3.6 ± 0.5 | 3.5 ± 0.5 | 3.6 ± 0.6 | NS |
| Ecological validity | 3.6 ± 0.6 | 3.6 ± 0.6 | 3.7 ± 0.6 | NS |
| Negative effects | 2.4 ± 0.8 | 2.7 ± 0.9 | 2.0 ± 0.7 | 0.04 |
| User enjoyment | 3.9 ± 1.0 | 4.0 ± 1.0 | 3.8 ± 1.1 | NS |
| Stress (score 1 – 12.42) | ||||
| Pre-exposure | 3 ± 2.4 | 3.7 ± 2.6 | 2.4 ± 2.2 | NS |
| Post-exposure | 2.7 ± 2.4 | 2.9 ± 2.7 | 2.5 ± 2.1 | |
| Arousal (score 1 – 9.78) | ||||
| Pre-exposure | 6.3 ± 2.2 | 5.4 ± 2.2 | 7.3 ± 1.9 | NS |
| Post-exposure | 6.5 ± 2.2 | 6.5 ± 2.1 | 6.5 ± 2.4 | |
| Total (score 0 – 235.62) | ||||
| Pre-exposure | 11 ± 13.8 | 16 ± 17.2 | 5 ± 6.4 | NS |
| Post-exposure | 25 ± 23.9 | 30 ± 26.6 | 19 ± 20.2 | |
| Nausea (score 0 – 200.34) | ||||
| Pre-exposure | 7 ± 11.3 | 11 ± 14.3 | 2 ± 4.2 | NS |
| Post-exposure | 25 ± 21.8 | 30 ± 21.6 | 21 ± 21.6 | |
| Oculomotor (score 0 – 200.34) | ||||
| Pre-exposure | 10 ± 13.9 | 15 ± 16.5 | 6 ± 8.8 | NS |
| Post-exposure | 17 ± 18.1 | 22 ± 22.3 | 11 ± 10.6 | |
| Disorientation (score 0 – 200.34) | ||||
| Pre-exposure | 10 ± 15.8 | 14 ± 19.7 | 6 ± 9.6 | NS |
| Post-exposure | 23 ± 30.1 | 26 ± 32.5 | 20 ± 28.0 | |
| Trial 1 | 1.6 ± 1.9 | 1.9 ± 2.4 | 1.2 ± 1.4 | 0.29 |
| Trial 2 | 1.6 ± 2.0 | 2.1 ± 2.4 | 1.1 ± 1.4 | 0.15 |
| Trial 3 | 1.6 ± 1.9 | 1.9 ± 1.8 | 1.3 ± 2.1 | 0.42 |
| Trial 4 | 1.7 ± 2.3 | 2.5 ± 2.7 | 0.9 ± 1.6 | 0.03 |
FIGURE 2This figure shows the effects of VR exposure on total, nausea, oculomotor, and disorientation levels in the younger and older adults. While symptoms associated each subdomain were enhanced after VR exposure, total sickness levels were less than 15 for both age groups, suggesting that overall adverse effects were minimal. No group differences were observed on the changes scores. ∗indicates that a significant difference in symptom severity was found pre-post within an age group.
FIGURE 3This figure shows the effects of VR exposure on stress and arousal states in participants. No significant differences were found for group or time.
FIGURE 4This figure compares presence factors in younger and older adults for the ITC-SOPI questionnaire. Younger adults experienced higher levels of negative effects than older adults. ∗indicates that a significant difference was found between younger and older adults with negative effects.
FIGURE 5(A) Shows that perceived physical exertion levels increases appropriately with time spent in the virtual environment. Younger adults were within the target exercise zone while older adults were approaching it. (B) Shows SSC total sickness levels after each trial. No association was found between duration of exposure and symptom severity.